Paramedic Eddie Barnes saved a life with skills he wasn't authorized to use — prompting an investigation that reveals the ...

A week after Paloma Shemirani was diagnosed with the blood cancer non-Hodgkin lymphoma in December 2023, she FaceTimed her ...

The kids are alright — on GLP-1s, that is. A new study found that the blockbuster treatment Mounjaro can dramatically lower blood sugar and body weight in children as young as 10 with Type 2 diabetes.

Blood thinners are often prescribed to prevent life-threatening clots. One type, called direct oral anticoagulants (DOACs), ...

Paramedic Amy Leigh has shared an 'incredibly effective' approach to treating some of her patients' sickness and nausea ...

Weight-loss surgery might have a better impact on health than GLP-1 drugs People lost more weight after surgery compared to the drugs They also had fewer health problems like heart or kidney disease ...

About 12 million adults in the United States are affected by PTSD, impacting between 4% and 8% of the adult population – and up to 30% of military personnel and veterans.

The new class of anti-obesity drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), is proving remarkably effective at helping individuals lose weight. However, a new population-wide study ...

For some GLP-1 users, the road from slim to grim is short. Surveys show that nearly 12% of Americans have turned to Ozempic, Wegovy or similar drugs to lose weight, with prescriptions more than ...

For years, the pancreas has been being taught in biology class as an easy system: insulin lowers blood sugar, and glucagon raises it. But that’s much too simple, new research says. Scientists at Duke ...

BOTHELL, Wash. - Cocrystal Pharma, Inc. (NASDAQ:COCP), a $14.77 million market cap biotechnology company trading at $1.44 per share, has received FDA clearance to proceed with a Phase 1b human ...

Novo Nordisk (NVO) shares rose 6% premarket on Thursday, their biggest gain in a month, after a real-world study showed its diabetes drug Ozempic outperformed Eli Lilly’s (NYSE:LLY) older drug ...